A pilot study evaluating the safety and efficacy of modafinal for cancer-related fatigue

Journal of Palliative Medicine

Volumn 12, Issue 5, 2009, Pages 433-439

  Blackhall, Leslie ^a   Petroni, Gina ^b   Shu, Jianfen ^b   Baum, Lora ^c   Farace, Elena ^d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MODAFINIL;

ABDOMINAL PAIN; ADULT; ARTICLE; BLURRED VISION; CANCER FATIGUE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; COGNITION; DEPRESSION; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG SELF ADMINISTRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT INVENTORY; FUNCTIONAL STATUS; HEADACHE; HEARING DISORDER; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INSOMNIA; MALE; NAUSEA; PATIENT ASSESSMENT; QUALITY OF LIFE; SINUS TACHYCARDIA; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; WELLBEING;

ACTIVITIES OF DAILY LIVING; AFFECT; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG TOXICITY; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PILOT PROJECTS; QUALITY OF LIFE; VIRGINIA;

EID: 66749125910     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2008.0230     Document Type: Article

References (38)

1. Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, Donnelly J, Eisenberger MA, Escalante C, Hinds P, Jacobsen PB, Kaldor P, Knight SJ, Peterman A, Piper BF, Rugo H, Sabbatini P, Stahl C; National Comprehensive Cancer Network: NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology (Williston Park) 2000;14:151-161.
2. Glaus A, Crow R, Hammond S: A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Support Care Cancer 1996;4:82-96.
3. Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM, Johnson DH, Miaskowski C, Scherr SL, Portenoy RK, Vogelzang NJ: Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. Oncologist 2000;5:353-360
4. Curtis EB, Kretch R, Walsh TD: Common symptoms in patients with advanced cancer. J Palliat Care 1991;7:25-29.
5. Portenoy RK, Thaler HT, Kornbluth AB, Lepore JM, Friedlander-Klar H, Coyle N, Smart-Curley T, Kemeny N, Norton L, Hoskins W, et al: Symptom prevalence characteristics and distress in a cancer population. Qual Life Res 1994;3:183-189.
6. Cella D, Davis K, Breitbart W, Curt G; for the Fatigue Coalition: Cancer-related fatigue prevalence of proposed diagnostic criteria in a US sample of cancer survivors. J Clin Oncol 2001;19:3385-3391.
7. Sugawara Y, Akechi T, Okuyama T Matsuoka Y, Nakano T, Inagaki M, Imoto S, Fujimori M, Hosaka T, Uchitomi Y: Occurrence of fatigue and associated factors in disease-free breast cancer patients without depression. Support Care Cancer 2005;13:628-636.
8. Minton O, Richardson A, Sharpe M, Hotopf M, Stone P: A systematic review and meta-analysis of the pharmacologic treatment of cancer related fatigue. J Natl Cancer Inst 2008;100:1155-1166.
9. Hanna A, Sledge G, Mayer ML, Hanna N, Einhorn L, Monahan P, Daggy J, Bhatia S: A phase II study of methyl-phenidate for the treatment of fatigue. Support Care Cancer 2006;14:210-215.
10. Sarhill N, Walsh D, Nelson KA, Homsi J, LeGrand S, Davis MP: Methylphenidate for fatigue in advanced cancer: A prospective open-label pilot study. Am J Hosp Palliat Care 2001;18:187-192.
11. Bruera E, Driver L, Barnes EA, Willey J, Shen L, Palmer JL, Escalante C: Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: A preliminary report. J Clin Oncol 2003;21:4439-4443.
12. Sugawara Y, Akeshi T, Shima Y, Okuyama T, Akizuki N, Nakano T, Uchitomi Y: Efficacy of methylphenidate for fatigue in advanced cancer patients: A preliminary study. Palliat Med 2002;16:261-263.
13. Fleishman S, Lower E, Zeldis J, Faleck H, Manning D: A phase II randomized, placebo controlled trial of the safety and efficacy of dex-methylphenidate as a treatment for fatigue and "chemobrain" in adult cancer patients. Breast Cancer Res Treat 2005;94:S214.
14. Bruerea E, Valero V, Driver D, Shen L, Willey J, Zhang T, Palmer JL: Patient-controlled methylphenidate for cancer fatigue: A double-blind, randomized, placebo-controlled trial. J Clin Oncol 2006;24:2073-2078.
15. Berkovitch M, Pope E, Phillips J, Koren G: Pemoline associated fulminant liver failure: Testing the evidence for causation. Clin Phamacol Ther 1995;57:696-698.
16. US Modafinil in Narcolepsy Multicenter Study Group: Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 1998;43: 88-97.
17. Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN: Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: A two centre phase 2 study. J Neurol Neurosurg Psychiatry 2002;72:179-183.
18. Zifko J, Rupp M, Schwarz S, Zipko H, Maida E: Modafinal in treatment of fatigue in multiple sclerosis. J Neurol 2002;249: 983-987.
19. MacDonald JR, Hill JD, Tarnopolsky MA: Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy. Neurology 2002;59:1876-1880.
20. Happe S, Pirker W, Sauter C, Klosch G, Zeitlhofer J: Successful treatment of excessive daytime sleepiness in Parkinson's disease with modafinil. J Neurol 2001;248:632-634.
21. Hagle B, Saletu M, Brandauer E, Glatzl S, Frauscher B, Seppi K, Ulmer H, Wenning G, Poewe W: Modafinil for the treatment of daytime sleepiness in Parkinson's disease: A double-blind, randomized, crossover, placebo controlled polygraphic trial. Sleep 2002;25:905-909.
22. Adler CH, Caviness JN, Hentz JG, Lind M, Tiede J: Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Mov Disord 2003:18:287-293.
23. DeBattista C, Lembkhe A, Solvason HB, Ghebremichael R, Poirier J: A prospective trial of modafinil as an adjunctive treatment for major depression. J Clin Psychopharm 2004;24: 87-90.
24. Vaishnavi S, Gadde K, Alamy S, Zhang W, Connor K, Davidson JR: Modafinil for atypical depression: Effects of open-label and double-blind discontinuation treatment. J Clin Psychopharm 2006;26:373-378.
25. DeBattista C, Doghramji K, Menza MA, Rosenthal MH, Fieve RR; Modafinil in Depression Study Group: Adjunct modafinil for the short term treatment of fatigue and sleepiness in patients with major depressive disorder: A preliminary double-blind placebo controlled study. J Clin Psychiatry 2003;64:1057-1064.
26. Fava M, Thase ME, Debattista C: A multi-center, placebo-controlled study of modafinil augmentation in partial re-sponders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J Clin Psychiatry 2005;66: 85-93.
27. Lin JS, Hou Y, Jouvet M: Potential brain neuronal targets for amphetamine-, methylphenidate and modafinil-induced wakefulness, as evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci USA. 1996;93:14128-14133.
28. Hou RH, Freeman C, Langley RW, Szabadi E, Bradshaw CM: Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and au-tonomic functions in human volunteers. Psychopharma-cology 2005;181:537-549.
29. Mendoza T, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL: The rapid assessment of fatigue severity in cancer patients: Use of the Brief Fatigue Inventory. Cancer 1999;85:1186-1196.
30. Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370.
31. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, et al: The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure J Clinical Oncol 1993;11:570-579.
32. Collin C, Wade DT, Davies, Horn V: The Barthel ADL Index: A reliability study. Int Disabil Stud 1998;10:61-63.
33. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655.
34. Brandt J: The Hopkins Verbal Learning Test: Development of a new memory test with six equivalent forms. Clin Neuropsychol 1991;5:125-142.
35. Matthews CG, Kleve H: Instruction Manual for the Adult Neuropsychology Test Battery. Madison, WI: University of Wisconsin Medical School, 1964.
36. Benton AL, Hamsher K deS: Multilingual Aphasia Examination Manual revised. Iowa City: University of Iowa, 1978.
37. Reitan RM: Validity of the Trail Making Test as an indicator of organic brain damage. Percept Motor Skills 1958;8:271-276.
38. Ahles TA, Silberfarb PM, Herndon J 2nd, Maurer LH, Kornblith AB, Aisner J, Perry MC, Eaton WL, Zacharski LL, Green MR, Holland JC: Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: A study by the Cancer and Leukemia Group B. J Clin Oncol 1998;16:1954-1960.